INDBInternet News Database 2.5 Updated 2 min ago · 284 sources Show or hide images Light or dark

Is It Time to Change the SoC for Fit Patients With AML?

1 source1 article First seen Updated United States Truth score 38

Save Like Comments Compare coverage

Summary

Phase 2 findings suggest that fit patients with AML fare better with a gentler regimen than with standard induction chemotherapy. Is it enough to change decades-old practice?

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    Is It Time to Change the SoC for Fit Patients With AML?

    Phase 2 findings suggest that fit patients with AML fare better with a gentler regimen than with standard induction chemotherapy. Is it enough to change decades-old practice?

Comments

Comments need JavaScript.